cautioning about the use of albumin in seriously ill patients
November 1998
Experts are now cautioning about the use of albumin in seriously ill patients.
A recent review in the British Medical Journal suggests a 6% HIGHER mortality when albumin is given to patients with hypovolemia...burns...or hypoproteinemia.
This would mean one excess death per 17 treated patients.
Practical advice for a better career, with unlimited access to CE
Pharmacy Technician's Letter Canada includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 120+ CE courses, including the popular CE-in-the-Letter
- Helpful, in-depth Technician Tutorials
- Access to the entire archive
Already a subscriber? Log in
Volume pricing available. Get a quote